Skip to main content

Table 1 The rest important blood and sputum testing indicators of pre- and post-treatment with Crizotinib

From: Fatal interstitial lung disease associated with Crizotinib pathologically confirmed by percutaneous lung biopsy in a patient with ROS1-rearranged advanced non-small-cell lung cancer: a case report

 

Blood testing indicators

Sputum indicators

Carbohydrate antigen 199 (IU/ml)

Cytokeratin fragment (ug/L)

Neuron-specific enolase (ug/L)

Squamous cell carcinoma antigen (ug/L)

White blood cell count (× 109/L)

Erythrocyte sedimentation rate (mm/h)

C-reactive protein (mg/L)

Sputum culture

Normal range

0.0~ 37.0

0.00~ 7.00

0.00~ 10.00

0.00~ 2.50

3.5~ 9.5

0~ 20

0~ 8

NA

Pre-treatment

100.8

14.31

4.85

22.94

11.3

32

95.1

negative

Post-treatment

57.3

15.14

5.84

7.89

16.7

10

4.1

negative